Market Overview

Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal

Share:
Related MYL
Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent
Cramer Weighs In On Transocean LTD, Mylan Inc And Honda Motor Co Ltd
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog (Zacks)

This statement is made by the Board of Directors (the ”Board”) of Meda AB pursuant to the Securities Markets Act and/or the Financial Instruments Trading act.

The Board hereby confirms that it has been contacted by Mylan, Inc. (NYSE: MYL) regarding an indicative proposal to combine the two businesses. The Board has convened and has decided to reject the proposal. All continued discussions between Meda and Mylan have been terminated without further actions.

The Board of Directors

Posted-In: News M&A

 

Related Articles (MYL)

Around the Web, We're Loving...

Get Benzinga's Newsletters